These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27041209)

  • 41. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
    Simmonds P; Loomis E; Curry E
    Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.
    Li B; Shi XB; Nori D; Chao CK; Chen AM; Valicenti R; White Rde V
    Prostate; 2011 May; 71(6):567-74. PubMed ID: 20878953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic factors of individual radiosensitivity and adaptive capacity.
    Kravets AP; Sokolova DA
    Int J Radiat Biol; 2020 Aug; 96(8):999-1007. PubMed ID: 32396015
    [No Abstract]   [Full Text] [Related]  

  • 50. Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection.
    Belli M; Tabocchini MA
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data.
    Fortin JP; Hansen KD
    Genome Biol; 2015 Aug; 16(1):180. PubMed ID: 26316348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible applications of biotechnology to radiotherapy.
    Weichselbaum RR
    Eur J Cancer; 1991; 27(4):405-7. PubMed ID: 1828165
    [No Abstract]   [Full Text] [Related]  

  • 53. Adenoviral treatment enhances tumour radiosensitivity.
    Furlow B
    Lancet Oncol; 2007 May; 8(5):376. PubMed ID: 17514804
    [No Abstract]   [Full Text] [Related]  

  • 54. Cured in a FLASH: Reducing Normal Tissue Toxicities Using Ultra-High-Dose Rates.
    Al-Hallaq H; Cao M; Kruse J; Klein E
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):257-260. PubMed ID: 31047621
    [No Abstract]   [Full Text] [Related]  

  • 55. CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting.
    Lu K; Li Z; Hu Q; Sun J; Chen M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic mechanisms underlying prostate cancer radioresistance.
    Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
    Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel
    Cabrera-Mulero A; Crujeiras AB; Izquierdo AG; Torres E; Ayers D; Casanueva FF; Tinahones FJ; Morcillo S; Macias-Gonzalez M
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31319558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate cancer: Radiotherapy induces epigenetic changes.
    Stone L
    Nat Rev Urol; 2016 May; 13(5):241. PubMed ID: 27041209
    [No Abstract]   [Full Text] [Related]  

  • 59. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
    Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
    Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.